Default company panoramic image

BioTalk Technologies, Inc.

BioTalk Technologies creates and develops innovative disruptive technologies designed to empower consumers to take charge of their health.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Dallas, TX, USA
  • Currency USD
  • Founded September 2008
  • Employees 5
  • Website

Company Summary

BioTalk Technologies creates and develops innovative tools designed to empower consumers to take charge of their health. Focusing on human health and rejuvenation, BioTalk specializes in precision diagnostic and healing technologies that will help millions of consumers attain their health and beauty goals. Our technologies target unmet needs within billion-dollar markets--advancing new, healthier alternatives for consumers.


  • Default avatar
    Sarah S. Stack
    Founder, Chief Executive Officer

    Sarah Stack is a forward-thinking entrepreneur who has founded a successful company, helped resuscitate existing enterprises, and has the enviable ability to consistently achieve targeted revenue goals. She was one of the founding pioneers in the “Disease Management” field in the 1990's & is now focusing all of these abilities and her wealth of experience to alter how consumers perceive and control their health. Sarah is married with 2 children.

  • Default avatar
    Brenda J. Fox
    Chief Operating Officer

    Playing an integral part in the management teams that created three separate high-tech startup enterprises, Brenda Fox has seen two of those endeavors grow to over $ 1.5 billion dollars per year in sales in less than 5 years. She has exhibited her executive leadership in these startups by carefully managing hyper-growth, while designing, building & managing large global teams responsible for product vision, development & mission critical systems.

  • Default avatar
    Mark Campbell
    Director of Research and Development

    A creative and innovative scientist, Mark Campbell has over thirty years' experience in solving complex scientific problems, with a deep understanding of interactions between energy and matter that has led to his developing techniques to manipulate both, with applications in chemistry, physics and engineering. His breakthroughs in control and manipulation of molecular structures provide the foundation for BioTalk's proprietary technologies.

  • Default avatar
    Robin A. Bernhoft, M.D.
    Chief Medical Officer

    Robin Bernhoft, MD, FAAEM, FACS is a former surgeon, educated at Harvard, Washington University St Louis, UCSF, and the Royal Postgraduate Medical School in London, UK. Dr. Bernhoft retrained in Environmental Medicine & thereafter became President of the American Academy of Environmental Medicine & Medical Director of the Bernhoft Center for Advanced Medicine in Brentwood & Ojai, CA. The author of 26 peer-reviewed papers in medicine and surgery.

  • Default avatar
    Nancy L. Gorsich
    Director of Communications

    Nancy Gorsich has been a Senior Executive Consultant in the areas of corporate vision; strategy, and communications; enterprise culture change; business process redesign; innovation development, and performance fulfillment. She has satisfied customers in countless industries, including: hi-tech, telecommunications, healthcare, utilities, energy & pharmaceutical industries. Nancy negotiated, directed, and managed large-scale corporate engagements.


  • Default avatar
    Joseph A. Hoffman Andrews Kurth, LLP Dallas, TX 75201
    Default avatar
    Howard J. Schulman Bulloch, DuPertuis, Schulman, Seger & Co., PC

Previous Investors

  • Default avatar
    Healthways, Inc. Thomas G. Cigarran, Charlene Gorzela,
    Default avatar
    Robin Bernhoft, M.D., Thomas B. Murphy, Nancy L. Gorsich,
    Default avatar
    James Zarvos, Eileen Stafford, Sherwood Wagner, Montgomery L. Toscano